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A sensitive and selective chemiluminescence assay for the determination of 
quinones was developed.  The method was based on generation of reactive oxygen 
species through the redox reaction between quinone and dithiothreitol as reductant, and 
then the generated reactive oxygen was detected by luminol chemiluminescence.  The 
chemiluminescence was intense, long-lived and proportional to quinone concentration.  It 
is concluded that superoxide anion was involved in the proposed chemiluminescence 
reaction because the chemiluminescence intensity was decreased only in the presence of 
superoxide dismutase.  Among the tested quinones, the chemiluminescence was observed 
from 9,10-phenanthrenequinone, 1,2-naphthoquinone and 1,4-naphthoquinone, whereas it 
was not observed from 9,10-anthraquinone and 1,4-benzoquinone.  The 
chemiluminescence property was greatly different according to the structure of quinones.  
The chemiluminescence was also observed for biologically important quinones such as 
ubiquinone.  Therefore, simple and rapid assay for ubiquinone in pharmaceutical 
preparation was developed based on the proposed chemiluminescence reaction.  The 
detection limit (blank + 3SD) of ubiquinone was 0.05 µM (9 ng/assay) with an analysis 
time of 30 seconds per sample.  The developed assay allowed the direct determination of 
ubiquinone in pharmaceutical preparation without any purification procedure.   
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Quinones have an important role to maintain biological functions of animal and 
plant.  Quinones including ubiquinone (coenzyme Q10) acts as electron carrier in 
mitochondrial electron transport chain [1], besides take part in the blood clot action as 
phylloquinone (vitamin K1) which is naphthoquinone derivative [2].  Recently, 
pyrroloquinoline quinone (PQQ), which is a redox cofactor of bacterial dehydrogenases, 
was reported as a vitamin for mice [3].  Moreover, in the process of photosynthesis cycle 
in plant and bacteria, it is well known that plastoquinone has an essential role.    In 
addition to these biological roles, quinones can be applied to wide variety of industrial 
usage.  Quinones are exploited as herbicide, bleaching reagent and cosmetic [4].  Some 
drugs have quinone structures, such as daunorubicin and doxorubicin, which are used as 
anti-tumor drugs [5].  Moreover, quinones existed in environment, including 9,10-
phenanthrenequinone, have become the focus of attention owing to their potential 
harmful effects on human health [6-8].  It is reported that quinones serves as a potent 
inhibitor of some biological functions such as nitric oxide synthase activity [9] and 
progesterone secretion [10].  Quinones are capable of generating reactive oxygen species 
(ROS) in biological system [11-13], which cause oxidative stress to living body.  From 
these aspects, a sensitive and selective determination method is required to clarify the 
activity and disposition of quinones in various fields. 
Several techniques have been developed for the determination of quinones 
including spectrofluorometry [14], electron spin resonance (ESR) assay [15], flow-




mass spectrometry (GC-MS) [17], high-performance liquid chromatography (HPLC) with 
UV [18-20], fluorescence (FL) [21], chemiluminescence (CL) [22] and electrochemical 
(ECD) detection [23-25].  However these techniques have disadvantages in the aspect of 
sensitivity, rapidity and simplicity.  Generally, UV absorbance method is less sensitive 
and less selective.  Because the quinones have no (or extremely weak) fluorescence, 
fluorometric methods require conversion reaction of quinone to fluorescent compound.   
Although the HPLC-ECD method is sensitive and is often used for the determination of 
quinones, the quinones should be reduced beforehand, thus the methods lack the 
simplicity and rapidity.  The GC-MS method needs complicated derivatization 
procedures to convert quinones to volatile compounds.  For the ESR analysis, special and 
expensive instrument is required.  Recently, we reported the novel determination methods 
for quinones by HPLC-FL [26] and CL methods [27].  Although these methods have 
great sensitivity and selectivity, the HPLC-FL method requires the pre-column 
derivatization reaction and the HPLC-CL method requires photoreactor for the 
photochemical reaction. 
In the present study, we focused on the phenomenon that the quinones produce 
reactive oxygen species (ROS) through their redox reaction cycle.  The quinones are 
reduced by dithiothreitol (DTT) as reductant to form semiquinone radical.  This 
semiquinone radical is oxidized to quinone under aerobic conditions.  In this way, 
dissolved oxygen is converted to ROS.  On the other hand, it is known that luminol emits 
strong luminescence by the reaction with ROS.  These reactions were combined to 




using typical quinones.  As an application studies of proposed CL assay, we developed 




Material and reagents 
 
9,10-Phenanthrenequinone, 1,2-naphthoquinone, 9,10-anthraquinone, 1,4-
benzoquinone and catalase from bovine liver (1600 U/mg) were purchased from Tokyo 
Chemical Industry (Tokyo, Japan).  1,4-Naphthoquinone, phylloquinone, DTT and 
ethanol were obtained from Nacalai Tesque (Kyoto, Japan).  Luminol and superoxide 
dismutase (SOD) from bovine erythrocytes (4470 U/mg) were purchased from Sigma (St. 
Louis, MO, USA) and sodium hydroxide (NaOH) was from Merck (Tokyo, Japan).  
Acetonitrile (HPLC grade), PQQ and ubiquinone were from Kanto Chemical (Tokyo, 
Japan).   Purified water was prepared by a Simpli Lab UV (Millipore, Bedford, MA, 
USA) water device.  The ubiquinone containing drugs (tablet and granules) were obtained 
from Eisai Pharmaceuticals (Tokyo, Japan).  Other chemicals were of extra pure grade.  
Stock solutions of quinones except for ubiquinone were prepared in acetonitrile and 
diluted appropriately with acetonitrile to prepare the working solutions.  Stock solution of 
ubiquinone was prepared in ethanol and diluted with ethanol.  Solutions of DTT and 






Assay procedure for typical quinones 
 
In a small test tube, 100 µL of quinone solution and 100 µL of 150 µM luminol 
dissolved in 6 mM NaOHaq. was mixed.  The test tube was placed in Lumat LB-9507 
luminometer (Berthold) and then 100 µL of 50 µM DTT acetonitrile solution was 
injected automatically, and the produced CL was measured for 600 s.  The total intensity 
was defined as the area under the CL delay curve.  Data was expressed as the mean of 
triplicate measurements. 
 
Determination of ubiquinone in pharmaceutical preparations 
 
The tablets were ground and equivalent amount to one tablet was dissolved in 5.8 
mL of ethanol and then a 20 µL aliquot of the solution after filtration with 0.45 µm pore 
size membrane filter was diluted 100 times with ethanol.  A 10 µL of the diluted solution 
was transferred to small tube and diluted 20 times with ethanol.  A 200 µL of 400 µM 
luminol dissolved in 160 mM NaOHaq. was added in the small tube containing 200 µL of 
standard ubiquinone solution or diluted sample and then 200 µL of 20 mM of the DTT 
solution was automatically injected into the tube in luminometer LB-9507.  The produced 
CL was measured for 30 s and the total CL intensity was integrated.  For granules, thirty-
five mg of granules was dissolved in 20 mL of ethanol and then treated by the similar 





Results and discussion 
 
Mechanism of CL reaction 
 
A strong CL was emitted after the addition of DTT to the mixture of luminol and 
9,10-phenanthrenequinone, and continued for more than 10 min.  Figure 1 shows the time 
profiles of CL emission obtained at different 9,10-phenanthrenequinone concentrations.  
As increasing the 9,10-phenanthrenequinone concentration, the CL intensity increased 
and the time needed to reach the maximum CL intensity reduced accordingly.  The higher 
concentration of 9,10-phenanthrenequinone enhanced the CL emission and accelerated 
the CL reaction.  It was thought that some ROS had been generated in the reaction 
mixture because luminol emits CL when it reacts with ROS.  In addition, since the 
significant CL was not observed in the absence of 9,10-phenanthrenequinone or DTT 
(Fig. 2), both 9,10-phenanthrenequinone (quinone) and DTT (reductant) should play a 
key role in the proposed CL reaction.  Therefore, we considered that ROS was generated 
from the reaction between 9,10-phenanthrenequinone and DTT. 
It has been reported that quinones are reduced to semiquinones by NAD(P)H 
cytochrome P450 reductase and these semiquinones can be recycled to the original 
quinones along with the formation of ROS [7].  Kumagai et al. reported that superoxide 
anion was generated during the reaction of 9,10-phenanthrenquinone with DTT [13].  
Yamashoji and Takeda developed the CL assay for bacteria viability, which is based on 
the generation of ROS through the reduction of menadione (2-methyl-1,4-




were detected by luminol CL and the CL intensity was proportional to the viability of 
bacteria.  
In order to elucidate the ROS in relation to proposed CL reaction, we investigated 
the quenching of CL of 9,10-phenanthrenequinone in the presence of selective ROS 
scavenger (Table 1).  ROS scavenger dissolved in water (20 µL) was added in the 
mixture of 9,10-phenanthrenequinone, DTT and luminol, and then the CL was measured.  
The CL intensity was significantly diminished in the presence of SOD that decomposes 
the superoxide anion selectively.  On the other hand, the CL was not quenched drastically 
in the presence of mannitol, sodium azide (NaN3) and catalase.  Therefore, we concluded 
that superoxide anion was the main ROS generated through the redox reaction of 9,10-
phenanthrenequinone with DTT. 
In consideration of the above-mentioned studies, we presume that the possible CL 
mechanism as follows (Fig. 3):  (1) the quinones are reduced by DTT to generate 
semiquinone radicals.  (2) semiquinone radicals convert dissolved oxygen to superoxide 
anion, and are oxidized to the original quinones (3) CL was emitted by the reaction 
between the superoxide anion and luminol.  The long-lived CL may be attributed to the 
continuous generation of superoxide anion by the repetition of redox cycle reaction of 
quinones.  
 
CL properties  
 
As a preliminary study, we investigated the effect of the different kinds of thiol 




examined reductants, DTT gave the strongest CL and was selected as reductant.  The 
effect of DTT concentration on the CL reaction of 9,10-phenanthrenequinone was 
investigated.  The CL intensity increased as increasing the DTT concentration.  However, 
the time for maximum CL intensity was delayed in the presence of higher concentration 
of DTT (Fig. 4).  The higher concentration of DTT compared with 9,10-
phenanthrenequinone might reduce the semiquinone radical to quinol (hydroquinone), 
and subsequently quinol interacted with quinone to yield the semiquinone radicals [29].  
This reaction route might be a reason for the delay of the CL.  The concentration ratio of 
9,10-phenanthrenequinone and DTT may determine the rate of the CL reaction.  On the 
other hand, the concentrations of luminol and NaOH did not significantly affect the 
kinetic profile of CL of 9,10-phenanthrenequinone.   
Under the experimental conditions described in assay procedure for typical 
quinones, the CL intensities of other typical quinones such as 1,2-naphthoquinone, 1,4-
naphthoquinone, 9,10-anthraquinone and 1,4-benzoquinone were measured.  The CL 
intensities obtained from 1,2-naphthoquinone and 1,4-naphthoquinone were 
approximately 0.7 and 0.4 times of that from the same concentration of 9,10-
phenanthrenequinone, respectively.  In contrast, no significant CL was observed from 
9,10-anthraquinone and 1,4-benzoquinone.  The order of CL intensities is 9,10-
phenanthrenequinone>1,2-naphthoquinone>1,4-naphthoquinone, which is in agreement 
with the order of ROS production capacity reported by Lemaire and Livingstone [12].  
They also reported that the rate of ROS production of 9,10-anthraquinone and 1,4-
benzoquinone was much lower than those of 9,10-phenanthrenequinone, 1,2-




benzoquinone might not be detected within 600 s because of their slow ROS production 
rates.  In addition, Rodriquez et al. reported that 9,10-anthraquinone and 1,4-
benzoquinone could not exhibit toxicity associated with the ROS generation [30].  Figure 
5 shows the time profiles of CL emission obtained from 1,2-naphthoquinone and 1,4-
naphthoquinone.  The CL time profiles were apparently different between these structural 
isomers.  It has been reported that p-quinone is reduced to semiquinone radical by single-
electron reduction [31] whereas o-quinone is reduced to quinol by two-electron reduction 
[29, 32].  The difference of reduction behavior between p-quinone and o-quinone might 
influence the formation rate of semiquinone radical.  Slow CL reaction of o-quinone such 
as 1,2-naphthoquinone might be explained from that certain amount of o-quinone was 
reduced to o-quinol and then covert to o-semiquinone radical.  On the other hand, p-
quinone such as 1,4-naphthoquinone gives a fast CL reaction because p-semiquinone 
radical might return rapidly to p-quinone without reducing to p-quinol.  This might 
attribute to the difference between the CL profiles obtained from 1,4-naphthoquinone and 
1,2-naphthoquinone.  However, the further experiments will be required to elucidate the 
relationship between CL property and structure of quinone. 
 The CL of the biologically important quinones such as ubiquinone, phylloquinone 
and PQQ was also measured by the proposed CL assay and the intense CLs were 
observed for these quinones.  Figure 6, 7 and 8 show the time profiles of CL emission 
obtained from ubiquinone, phylloquinone and PQQ, respectively, under the optimized 
conditions for each quinone.  The proposed method can also be applied to the 





Application of CL assay for ubiquinone to pharmaceutical preparations 
 
The proposed CL assay was applied to the determination of ubiquinone in the 
pharmaceutical preparations.  It is well known that ubiquinone is prescribed for heart 
disease such as congestive heart failure.  For the routine quality control of ubiquinone 
preparations, rapid and reliable analytical methods are desirable.  As shown in Figure 6, 
though the maximum CL intensity was reached at about 300 s, the integration time of the 
CL intensity was set at 30 s in consideration the rapidity of the assay.  
 To obtain strong CL intensity and maximum signal to blank (S/B) ratio, the 
reagent concentrations were examined.  The effects of DTT concentrations ranging from 
5 to 30 mM on CL intensity and S/B ratio were examined, and 20 mM of DTT was 
selected because the concentration gave the highest CL intensity and S/B ratio.  The 
effects of luminol concentration ranging from 100 to 700 µM on CL intensity and S/B 
ratio were investigated.  It was found that CL intensity increased by increasing the 
luminol concentration whereas S/B ratio increased till the concentration with 400 µM and 
then decreased.  Therefore, 400 µM luminol was employed.  Moreover, the optimum 
concentration of NaOH was investigated ranging from 75 to 275 mM.  The CL intensity 
increased with increasing NaOH concentration but the S/B ratio was reached maximum at 
160 mM and thus 160 mM of NaOH was selected. 
 A calibration curve was prepared for standard ubiquinone solution; a good linear 
relationship (r=0.997) between concentration and CL intensity was obtained in the 
concentration ranges of 0.3-6.0 µM.  The regression equation (mean ± SD, n=3) of the 




represent the integrated CL intensity and the ubiquinone concentration, respectively.  The 
detection limit (blank + 3 SD) of ubiquinone was 0.05 µM (9 ng/assay).  The sensitivity 
of the method for ubiquinone was approximately 60-, 25 and 2 times higher than those of 
ESR assay [15], spectrophotometry [33] and voltammetry [34], respectively.  Moreover, 
the proposed  CL method allowed rapid determination of ubiquinone.  The repeatability 
of the method was determined using three levels of ubiquinone.  As shown in Table 2, the 
relative standard deviations (RSD) for within-day analyses were less than 2.6% and 
between-day analyses were less than 6.8%, the sufficient repeatability of the assay was 
proved. 
The effect of some possible additives used in pharmaceutical preparations on CL 
intensity of ubiquinone was studied.  The CL of 1.0 µM of ubiquinone was measured in 
the absence and presence of 20 µL of the possible additives (Table 3).  There are no 
significant interferences even in the presence of 500 or 1000 times molar excess of 
additives against ubiquinone.  Finally, the proposed method was applied to the 
determination of ubiquinone in two forms of pharmaceutical preparations.  As shown in 
Table 4, it was clear that the measured values determined by the proposed CL method 
were in good agreement with both the indicated values and the values determined by 




A unique and novel CL assay for quinones was established.  By mixing quinones 




proportional to the concentration of quinones.  We concluded that the superoxide anion 
was generated through the redox reaction of quinones initiated by DTT and could be 
detected by luminol CL.  The proposed CL assay for quinones should be selective 
because the most chemicals do not undergo a reversible redox cycle that produces the 
ROS by the reaction with reductant such as DTT.  Actually, possible excipient additives 
and several ROS scavengers except for SOD did not affect the CL of quinones.  
Furthermore, the background signal is extremely low because the proposed assay does 
not require the addition of any oxidant, which reacts with luminol and causes high 
background signal.  As an application study, the developed CL assay allowed a simple 
and rapid analysis of ubiquinone in pharmaceutical preparations.  The proposed CL 
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Figure captions  
 
Fig. 1.  Time profiles of CL emission obtained from 0.4 to 0.9 µM of 9,10-
phenanthrenequinone.  The concentrations of DTT, luminol and NaOH are 50 µM, 150 
µM and 6 mM, respectively. 
 
Fig. 2. CL emission obtained from a mixture of (A) 0.9 µM 9,10-phenanthrenequinone, 
50 µM DTT and 150 µM luminol; (B) 0.9 µM 9,10-phenanthrenequinone and 150 µM 
luminol; (C) 50 µM DTT and 150 µM luminol.  CL was not observed at all in the absence 
of luminol. 
 
Fig. 3.  Deduced CL mechanism for quinones. 
 
Fig. 4.  Effect of DTT concentration on time profile of CL emission for 1.0 µM of 9,10-
phenanthrenequinone.  DTT concentrations are (A) 1.0, (B) 5.0 and (C) 50 µM.  The 
concentrations of luminol and NaOH are 150 µM and 6 mM, respectively. 
 
Fig. 5.  Time profiles of CL emission obtained from 0.8 µM of (A) 1,2-naphthoquinone 
and (B) 1,4-naphthoquinone.  The concentrations of DTT, luminol and NaOH are 50 µM, 





Fig. 6.  Time profiles of CL emission obtained from 0.8 µM of ubiquinone.  The 
concentrations of DTT, luminol and NaOH are 20 mM, 400 µM and 160 mM, 
respectively. 
 
Fig. 7.  Time profiles of CL emission obtained from 10 µM of phylloquinone.  The 
concentrations of DTT, luminol and NaOH are 5 mM, 350 µM and 70 mM, respectively. 
 
Fig. 8.  Time profiles of CL emission obtained from 0.1 µM of PQQ.  The concentrations 
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Fig. 1. Time profiles of CL emission obtained from  0.4 to 0.9 µM of 9,10-
phenanthrenequinone.  The concentrations of DTT, luminol and 






































































Fig. 2. CL emission obtained from a mixtureof (A) 0.9 µM 9,10-
phenanthrenequinone, 50 µM DTT and 150 µM luminol; (B) 0.9 µM 
9,10-phenanthrenequinone and 150 µM luminol; (C) 50 µM DTT and 












































0 200 400 600
Fig. 4. Effect of DTT concentration on time profile of CL emission for 1.0 µM of 
9,10-phenanthrenequinone. DTT concentrations are (A) 1, (B) 5 and (C) 
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Fig. 5. Time profiles of CL emission obtained from 0.8 µM of (A) 1,2-
naphthoquinone and (B) 1,4-naphthoquinone.  The concentrations of 
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Fig. 6. Time profiles of CL emission obtained from 0.8 µM of ubiquinone.  The 































0 200 400 600
Fig. 7. Time profiles of CL emission obtained from 10 µM of phylloquinone.  
The concentrations of DTT, luminol and NaOH are 5 mM, 350 µM and 
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Fig. 8. Time profiles of CL emission obtained from 0.1 µM of PQQ.  The 



























Table 1 Effect of ROS scavengers on CL of 9.10-phenanthrenequinone 
Scavenger Concentration, µg/mL RCIa 
without scavenger   100 
SOD 0.21 (1 U/mL) 44 
 2.1 (10 U/mL) 13 
Catalase 0.63 (1 U/mL) 96 
 6.3 (10 U/mL) 94 
Mannitol 0.18 (1 µM) 102 
 18 (100 µM) 88 
NaN3 0.07 (1 µM) 97 
 6.5 (100 µM) 93 
aCL intensity of 1.0 µM of 9,10-phenanthrenequinone without scavenger  
was taken as 100. 
 
Table 2 Method repeatability for ubiquinone  
Ubiquinone, µM Precision (RSD, %) 
Within-day (n=5) Between-day (n=3) 
0.3 1.2 6.8 
1.0 2.6 5.4 





Table 3  Effect of possible additive on CL of ubiquinone 
Additivea Concentration, mM RCIb 
Without addtitive   100 
KCl 5 100 
MgCl2 5 100 
CaCl2 5 100 
Alanine 10 104 
Stearic acid 10 102 
Lactose 10 99 
aStearic acid was dissolved in ethanol, and others were dissolved in water. 
bCL intensity of 1.0 µM of ubiquinone without additive was taken as 100. 
 
Table 4 Ubiquinone in pharmaceutical preparations 
Formuation Measured value, mg (mean ± SD, n=5) Indicated value, mg
 Proposed CL method HPLC-UV methodc  
Tableta 9.9 ± 0.6 10.0 ± 0.3 10 
Granulesb 10.0 ± 0.5 10.0 ± 0.2 10 
a 10 mg/tablet.  
b 10 mg/g. 
c Japanese Pharmacopoeia XV 
 
